Needlefree port protection

marketwatch.com reported that the Ivera Medical Corporation today announced an exclusive license agreement with BD, for the worldwide rights to selected BD-issued and pending patents for an intravenous port protector designed to reduce the potential for healthcare-acquired bloodstream infections.

“The licensing agreement between BD and Ivera broadens our existing patent applications and removes potential patent issues so we can move forward with the worldwide marketing and sales of the Curos Port Protector,” Jack Saladow, Ivera Vice President of Marketing and Sales said.

Click here for the full story.

Other stories

• Needlestick reference list
• Flu – impact on blood supplies
• Posiflush pre-filled saline
• Clean hands campaign 2009
• Hydration of terminally ill patients
• Wireless may disrupt IV devices
• IV pumps in home care
• IV tubing holder
• Antibiotic lock technique
• Plasma expanders
• Antimicrobial copper
• Baxter receives clearance from FDA for ’silver’ needlefree

Add IVTEAM to Technorati Favorites